Business Context and Reporting Period
Company: Landec Corporation (Note: Input metadata referenced "LIFECORE BIOMEDICAL, INC." but the filing text is for Landec Corporation).
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Fiscal quarter and six months ended November 29, 2009.
Business Overview: Landec designs, develops, and sells temperature-activated polymer products. Operations are divided into three segments: Food Products Technology (Apio, Inc., selling fresh-cut produce and packaging), Commodity Trading (buy/sell of whole produce), and Technology Licensing (Intellicoat seed coatings and Intelimer polymers).
Key Financial Metrics
| Metric | Three Months Ended Nov 29, 2009 |
Six Months Ended Nov 29, 2009 |
Six Months Ended Nov 30, 2008 |
|---|---|---|---|
| Total Revenues | $60.9 million | $121.9 million | $129.8 million |
| Gross Profit | $7.4 million | $16.3 million | $17.7 million |
| Gross Margin | 12.2% | 13.4% | 13.6% |
| Operating Income | $2.3 million | $5.7 million | $6.8 million |
| Net Income (Common Stockholders) | $1.5 million | $3.7 million | $4.3 million |
| Diluted EPS | $0.06 | $0.14 | $0.16 |
| Cash & Equivalents (Nov 29, 2009) | $2.2 million | ||
| Marketable Securities (Nov 29, 2009) | $65.9 million | ||
| Total Debt | Negligible (Interest expense was $4k for the quarter) |
Material Changes vs. Prior Period
- Revenue Decline: Six-month revenues decreased 6% to $121.9 million compared to $129.8 million in the prior year. This was driven by a 22% drop in Commodity Trading revenues and a 13% drop in Technology Licensing revenues.
- Segment Performance:
- Food Products Technology: Revenues increased 3% (six months) due to a 14% increase in value-added unit sales, partially offset by a shift to lower-priced bag sales.
- Commodity Trading: Revenues fell 22% due to decreased export volumes (supply constraints) and a planned exit from domestic buy/sell business with Wal-Mart.
- Technology Licensing: Revenues declined 13% primarily due to the completion of license fee payments from Air Products.
- Liquidity Shift: Cash and cash equivalents dropped significantly from $43.5 million (May 31, 2009) to $2.2 million (Nov 29, 2009). This was primarily due to a net purchase of $43.2 million in marketable securities and $3.2 million in capital expenditures.
- Profitability: Net income applicable to common stockholders decreased 14% year-over-year for the six-month period, largely due to lower revenues and a decrease in interest income caused by lower market yields.
Outlook, Risks, and Management Commentary
- Capital Expenditures: The company completed a 40,000 square foot expansion of its Apio processing facility and purchased automation equipment, accounting for the majority of the $3.2 million in capital expenditures for the period.
- Liquidity Position: Management believes existing cash, cash equivalents, and marketable securities are sufficient to finance operations for at least the next twelve months.
- Key Risks:
- Economic Conditions: The global economic slowdown and volatility may reduce demand and affect customer creditworthiness.
- Customer Concentration: The top five customers accounted for 47% of revenues in the six-month period, with Costco Wholesale Corp. alone representing 19%.
- Supply Chain & Weather: Operations are subject to weather conditions affecting crop yields and prices. The company relies on single-source suppliers for certain raw materials.
- Regulatory: Food packaging products are subject to FDA regulations; agricultural operations face environmental and USDA regulations.
- Strategic Partnerships: An amended agreement with Monsanto (dated Nov 27, 2009) continues the licensing of Intellicoat technology for a two-year term with a purchase option.
Investor Verification Checklist
- Cash Deployment: Verify the rationale and expected yield for the $43.2 million net purchase of marketable securities, which significantly reduced liquid cash reserves.
- Customer Concentration: Assess the risk associated with Costco Wholesale Corp. representing 19% of total revenues and the top five customers representing 47%.
- Commodity Trading Exit: Confirm the timeline and financial impact of the planned exit from the domestic buy/sell business with Wal-Mart.
- Goodwill Valuation: Review the annual impairment testing of goodwill ($27.4 million) and intangible assets, given the company's reliance on fair value estimates.
- Related Party Transactions: Review the nature and volume of transactions with the Apio Chairman and Beachside Produce LLC, which are classified as related party items.